MENU
+Compare
RXRX
Stock ticker: NASDAQ
AS OF
Apr 28, 03:55 PM (EDT)
Price
$5.79
Change
+$0.07 (+1.22%)
Capitalization
2.3B

RXRX Recursion Pharmaceuticals Forecast, Technical & Fundamental Analysis

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RXRX with price predictions
Apr 22, 2025

RXRX in upward trend: price may jump up because it broke its lower Bollinger Band on April 04, 2025

RXRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 30 cases where RXRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RXRX's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 14, 2025. You may want to consider a long position or call options on RXRX as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RXRX just turned positive on April 11, 2025. Looking at past instances where RXRX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for RXRX moved below the 200-day moving average on April 09, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RXRX entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.226) is normal, around the industry mean (13.917). P/E Ratio (0.000) is within average values for comparable stocks, (62.940). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.781). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (26.882) is also within normal values, averaging (251.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RXRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RXRX is expected to report earnings to fall 7.92% to -48 cents per share on May 07

Recursion Pharmaceuticals RXRX Stock Earnings Reports
Q1'25
Est.
$-0.49
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.03
The last earnings report on February 28 showed earnings per share of -52 cents, missing the estimate of -40 cents. With 6.72M shares outstanding, the current market capitalization sits at 2.30B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

RXRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.35%
CRSP - RXRX
72%
Closely correlated
-2.15%
BEAM - RXRX
62%
Loosely correlated
-3.22%
NTLA - RXRX
60%
Loosely correlated
+1.59%
ABSI - RXRX
58%
Loosely correlated
-2.80%
PRME - RXRX
58%
Loosely correlated
-3.43%
More

Groups containing RXRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.35%
RXRX
(2 stocks)
81%
Closely correlated
-0.85%